Literature DB >> 15885089

Quantitative assessment of the glyoxalase pathway in Leishmania infantum as a therapeutic target by modelling and computer simulation.

Marta Sousa Silva1, António E N Ferreira, Ana Maria Tomás, Carlos Cordeiro, Ana Ponces Freire.   

Abstract

The glyoxalase pathway of Leishmania infantum was kinetically characterized as a trypanothione-dependent system. Using time course analysis based on parameter fitting with a genetic algorithm, kinetic parameters were estimated for both enzymes, with trypanothione derived substrates. A K(m) of 0.253 mm and a V of 0.21 micromol.min(-1).mg(-1)for glyoxalase I, and a K(m) of 0.098 mm and a V of 0.18 micromol.min(-1).mg(-1) for glyoxalase II, were obtained. Modelling and computer simulation were used for evaluating the relevance of the glyoxalase pathway as a potential therapeutic target by revealing the importance of critical parameters of this pathway in Leishmania infantum. A sensitivity analysis of the pathway was performed using experimentally validated kinetic models and experimentally determined metabolite concentrations and kinetic parameters. The measurement of metabolites in L. infantum involved the identification and quantification of methylglyoxal and intracellular thiols. Methylglyoxal formation in L. infantum is nonenzymatic. The sensitivity analysis revealed that the most critical parameters for controlling the intracellular concentration of methylglyoxal are its formation rate and the concentration of trypanothione. Glyoxalase I and II activities play only a minor role in maintaining a low intracellular methylglyoxal concentration. The importance of the glyoxalase pathway as a therapeutic target is very small, compared to the much greater effects caused by decreasing trypanothione concentration or increasing methylglyoxal concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885089     DOI: 10.1111/j.1742-4658.2005.04632.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

1.  Characterization of the gene encoding glyoxalase II from Leishmania donovani: a potential target for anti-parasite drugs.

Authors:  Prasad K Padmanabhan; Angana Mukherjee; Rentala Madhubala
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  Purification, crystallization and preliminary X-ray diffraction analysis of the glyoxalase II from Leishmania infantum.

Authors:  José Trincão; Marta Sousa Silva; Lídia Barata; Cecília Bonifácio; Sandra Carvalho; Ana Maria Tomás; António E N Ferreira; Carlos Cordeiro; Ana Ponces Freire; Maria João Romão
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-25

3.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of glyoxalase I from Leishmania infantum.

Authors:  Lídia Barata; Marta Sousa Silva; Linda Schuldt; Gonçalo da Costa; Ana M Tomás; António E N Ferreira; Manfred S Weiss; Ana Ponces Freire; Carlos Cordeiro
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

Review 4.  Methylglyoxal metabolism in trypanosomes and leishmania.

Authors:  Susan Wyllie; Alan H Fairlamb
Journal:  Semin Cell Dev Biol       Date:  2011-02-15       Impact factor: 7.727

5.  Optimization of time-course experiments for kinetic model discrimination.

Authors:  Nuno F Lages; Carlos Cordeiro; Marta Sousa Silva; Ana Ponces Freire; António E N Ferreira
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

6.  ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides.

Authors:  Sandra L Oza; Shoujun Chen; Susan Wyllie; James K Coward; Alan H Fairlamb
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

7.  Organogenic nodule development in hop (Humulus lupulus L.): transcript and metabolic responses.

Authors:  Ana M Fortes; Filipa Santos; Young H Choi; Marta S Silva; Andreia Figueiredo; Lisete Sousa; Fernando Pessoa; Bartolomeu A Santos; Mónica Sebastiana; Klaus Palme; Rui Malhó; Rob Verpoorte; Maria S Pais
Journal:  BMC Genomics       Date:  2008-09-29       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.